The Nova 301 Trial is looking to recruit approximately 25,000 people globally to see if an investigational mRNA vaccine can ...
A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...
Protection from shots like the flu vaccine typically takes a couple of weeks to kick in, so getting one now may offer ...
There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.
A paper shows how partnering with the community can lead to more inclusive health care, especially for individuals with ...
Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...
Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected ...
False claims erode public trust.
The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...
Several African and ex-Soviet countries have expressed interest in buying Russia's vaccine against smallpox and mpox viruses, ...
Breast cancer patients have been given fresh hope after a new vaccine showed "promise" in treating an aggressive form of ...
The spread of this disease could be dramatically reduced with comprehensive coverage of a hexavalent vaccine, which ...